- Is Your Family ‘CO Safe’ When Big Storms Hit?
- Bike-Linked Head Injuries Plummet for U.S. Kids, But Not Adults
- Magnets in Cellphones, Smartwatches Might Affect Pacemakers, FDA Warns
- Is Rise in Liver Damage Tied to More Drinking During Lockdowns?
- AHA News: Orthopedic Surgeon Becomes Patient After Stroke at 48
- With New Mask Guidance Comes the Challenge of Following It
- Health Highlights: May 14, 2021
- Vaping Ups Teens’ Odds for Asthma, Asthma Attacks
- Depression Even More Common With Heart Failure Than Cancer
- Can Some Movies Change Your Life? Maybe, Study Finds
New Additive Aids Blood Platelet Storage
THURSDAY, Dec. 10An additive that allows for more efficient storage of blood platelets up to five days has been approved by the U.S. Food and Drug Administration.
Platelets — the component that helps blood clot — are commonly used to prevent or treat bleeding, are given to people having chemotherapy to treat cancer, and are administered to people who don’t produce their own platelets, the agency said in a news release.
Currently, platelets are stored in a solution made from a component of blood plasma. The newly approved additive, InterSol, will free up some of the donor plasma for other purposes, the FDA said.
InterSol is derived from salt. It’s manufactured by Illinois-based Fenwal Inc.
More information
To learn more about blood platelets, visit the University of Oklahoma Health Sciences Center.
Source: HealthDay
